Osteoporosis International· 2018Q1· Review
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- 1,834citations
- Q1SCImago
- 2018year
Short summary
Updated European guidance for diagnosing and managing osteoporosis in postmenopausal women offers new insights into assessing fracture risk using bone microstructure and FRAX®, highlights the role of Fracture Liaison Services, and addresses long-term dietary impacts and increased risk upon drug cessation.
AI-generated from the title and abstract; the full text is not read.
Key points
- Updated European guidance for osteoporosis diagnosis and management in postmenopausal women.
- Incorporates new information on bone microstructure evaluation for fracture risk.
- Highlights the role of FRAX® and Fracture Liaison Services in secondary fracture prevention.
- Addresses long-term dietary intake effects and increased fracture risk upon treatment cessation.
AI-generated from the title and abstract; the full text is not read.
Abstract
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis. The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2013. This manuscript updates these in a European setting. Systematic reviews were updated. The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; monitoring of treatment; assessment of fracture risk; case-finding strategies; investigation of patients; health economics of treatment. The update includes new information on the evaluation of bone microstructure evaluation in facture risk assessment, the role of FRAX® and Fracture Liaison Services in secondary fracture prevention, long-term effects on fracture risk of dietary intakes, and increased fracture risk on stopping drug treatment. A platform is provided on which specific guidelines can be developed for national use.
The authors' abstract, as published at the source. Osteoporosis International, 2018 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Orthopedics and Sports Medicine
Orthopedics and Sports MedicineMedicine